OTTAWA (Reuters) - Canada on Friday authorized Pfizer-Biontech's bivalent COVID-19 vaccine booster for children 5 to 11 years of age, according to statement from Health Canada.
Pfizer-BioNTech's shots are designed to target the BA.4/BA.5 variants of Omicron as well as the original coronavirus variant, and is the first bivalent booster authorized in Canada for 5 to 11 years age group, Health Canada said.
(Reporting by Ismail Shakil in Ottawa)
Price
|
Change
|
5d. change
|
Capi.
| ||
|---|---|---|---|---|---|
| 25.26 USD | -3.84% | -0.51% | 143B | ||
| 86.71 USD | -1.57% | +0.63% | 20.9B | ||
